A. Kofler

The arylhydrocarbon receptor (AhR), but not the AhR-nuclear translocator (ARNT), is increased in hearts of patients with cardiomyopathy

T. Thalhammer, G. Maurer, G. Steiner, 2002, Virchows Archiv.

DOTA-Lanreotide: A Novel Somatostatin Analog for Tumor Diagnosis and Therapy1.

P. Angelberger, I. Virgolini, P. Smith-Jones, 1999, Endocrinology.

DOTA-lanreotide: a novel somatostatin analog for tumor diagnosis and therapy.

P. Angelberger, I. Virgolini, P. Smith-Jones, 1999, Endocrinology.

DOTA-lanreotide: a novel somatostatin analog for tumor diagnosis and therapy.

P. Angelberger, A. Kofler, T. Traub, 1999, Endocrinology.